Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKesson
Cerilliant
Julphar
Cipla
Mallinckrodt
Queensland Health
Express Scripts
Fuji

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,879,706

« Back to Dashboard

Summary for Patent: 5,879,706
Title: Valaciclovir tablets containing colloidal silicon dioxide
Abstract:A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a lubricant and a microcrystalline cellulose filler are present extragranularly has excellent hardness and friability properties while still maintaining lubrication of the tablet granules.
Inventor(s): Carter; Barry Howard (Kinston, NC), Tillman; Lloyd Gary (Carlsbad, CA)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC)
Application Number:08/875,172
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Dosage form; Process; Use;

Drugs Protected by US Patent 5,879,706

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,879,706

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9501127Jan 20, 1995
PCT Information
PCT FiledJanuary 19, 1996PCT Application Number:PCT/GB96/00111
PCT Publication Date:July 25, 1996PCT Publication Number: WO96/22082

International Family Members for US Patent 5,879,706

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece 3033677 ➤ Try a Free Trial
Hong Kong 1002851 ➤ Try a Free Trial
China 1131026 ➤ Try a Free Trial
China 1494898 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKinsey
AstraZeneca
Fuji
Johnson and Johnson
Daiichi Sankyo
Teva
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.